Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the accuracy of latent factor and sum scoring of the Hospital Anxiety and Depression Scale to screen for major depression: An individual participant data meta-analysis.

Journal of affective disorders·2026
Same author

Data-Driven Cutoff Selection for the Patient Health Questionnaire-9 Depression Screening Tool.

JAMA network open·2024
Same author

Depression prevalence of the Geriatric Depression Scale-15 was compared to Structured Clinical Interview for DSM using individual participant data meta-analysis.

Scientific reports·2024
Same author

Individual patient data meta-analysis estimates the minimal detectable change of the Geriatric Depression Scale-15.

Journal of clinical epidemiology·2024
Same author

Comparison of Patient Health Questionnaire-9, Edinburgh Postnatal Depression Scale and Hospital Anxiety and Depression - Depression subscale scores by administration mode: An individual participant data differential item functioning meta-analysis.

Journal of affective disorders·2024
Same author

Anxiety Screening Is Unlikely to Improve Mental Health Outcomes.

American family physician·2024
Same journal

Beyond general depression: Premenstrual interpersonal anger as a unique pathway to suicidal ideation in adolescent females with ADHD.

Journal of psychosomatic research·2026
Same journal

Function-based reorganization of general hospital psychiatry in Japan: A perspective.

Journal of psychosomatic research·2026
Same journal

Metabolic and psychiatric changes after laparoscopic sleeve gastrectomy in patients with mood disorders and metabolic syndrome.

Journal of psychosomatic research·2026
Same journal

Corrigendum to "Depression and psycho-existential correlates in cancer outpatients: A longitudinal real-life study" Journal of Psychosomatic Research, Volume 209, October 2026, 112886.

Journal of psychosomatic research·2026
Same journal

A quantitative and qualitative analysis of non-participation in cardiac rehabilitation: The role of psychological burden and experienced barriers.

Journal of psychosomatic research·2026
Same journal

Circadian rest-activity rhythm and sleep in women with fibromyalgia and other central sensitization syndromes.

Journal of psychosomatic research·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Reuptake inhibitors

Roy C Ziegelstein

    Journal of Psychosomatic Research
    |December 28, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
    08:29

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

    Published on: June 7, 2018

    Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
    07:48

    Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

    Published on: July 3, 2015

    Related Experiment Videos

    Last Updated: May 26, 2026

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
    10:29

    Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

    Published on: May 9, 2025

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm
    08:29

    Reinstatement of Drug-seeking in Mice Using the Conditioned Place Preference Paradigm

    Published on: June 7, 2018

    Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
    07:48

    Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

    Published on: July 3, 2015